These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 400151)

  • 1. [The role of amikacin in conditions requiring chemotherapy with aminoglycoside antibiotics].
    Mazzei T; Ciuffi M; Nicoletti P; Panero C; Mainardi GC; Mini E; Versari L
    G Ital Chemioter; 1979; 26(1-2):397-406. PubMed ID: 400151
    [No Abstract]   [Full Text] [Related]  

  • 2. Gram negative bone and joint infection: sixty patients treated with amikacin.
    Schurman DJ; Wheeler R
    Clin Orthop Relat Res; 1978; (134):268-74. PubMed ID: 365414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].
    Lode H; Grunert K; Koeppe P; Langmaack H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1684-6. PubMed ID: 1030080
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglycoside antibiotics. V. The 4'-deoxybutirosins (Bu-1975C1 and C2), new aminoglycoside antibiotics of bacterial origin.
    Kawaguchi H; Tomita K; Hoshiya T; Miyaki T; Fujisawa K
    J Antibiot (Tokyo); 1974 Jun; 27(6):460-70. PubMed ID: 4211790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amikacin in the child: efficacy, tolerance, effects on the intestinal microbial ecosystem].
    Mathieu H; Lambert-Zechovsky N; Beaufils F; Blum C; Binger E; Guillot M
    Nouv Presse Med; 1979 Oct; 8(42):3482-91. PubMed ID: 537901
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycoside antibiotics. IX. 1-N-acyl derivatives of kanamycin A (amikacin analogs).
    Naito T; Nakagawa S; Narita Y; Toda S; Abe Y
    J Antibiot (Tokyo); 1974 Nov; 27(11):851-8. PubMed ID: 4217789
    [No Abstract]   [Full Text] [Related]  

  • 9. [Susceptibility to antimicrobial agents of 2,060 strains of different bacteria isolated in infectious processes in children].
    Filloy L; Borjas E; Sierra A
    Bol Med Hosp Infant Mex; 1981; 38(1):13-21. PubMed ID: 7025858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.
    Wielunsky E; Drucker M; Cohen T; Reisner SH
    Isr J Med Sci; 1983 Nov; 19(11):1006-8. PubMed ID: 6662682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hospita-acquired infections with amikacin.
    Doughty SC; Martin RR; Greenberg SB
    Am J Med; 1977 Jun; 62(6):889-93. PubMed ID: 868903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with amikacin, a new aminoglycoside antibiotic.
    Theron FP; De Kock MA
    S Afr Med J; 1977 May; 51(21):746-8. PubMed ID: 327583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and laboratory evaluation of amikacin].
    Borowski J; Musierowicz A; Dzierzanowska D; Niedźwiecka M; Gruszecki W
    Pol Tyg Lek; 1979 Oct; 34(44):1721-5. PubMed ID: 514892
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination antibiotic therapy in pediatrics.
    Chadwick EG; Yogev R; Shulman ST
    Am J Med; 1986 Jun; 80(6B):166-71. PubMed ID: 3728528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
    Orsini JA; Benson CE; Spencer PA; Van Miller E
    Am J Vet Res; 1989 Jun; 50(6):923-5. PubMed ID: 2669575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the use of some new antibiotics in the therapy of neonatal infections due to gram-negative bacilli. II. Bacteriologic studies].
    Rosaschino F; Flaúto U; Marini A
    Minerva Pediatr; 1967 Sep; 19(38):1763-6. PubMed ID: 4305801
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amikacin in therapy].
    Marmo E
    Clin Ter; 1980 Apr; 93(1):21-4. PubMed ID: 7449329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.